Results of previous clinical trials suggested that glomerular hyperfiltration driven by the activation of SGLT2 and the renin-angiotensin-aldosterone system (RAAS) is the possible pathomechanism of diabetic nephropathy. Here, REN is linked to diabetic kidney disease.